(Press-News.org) Some strains of the avian H7N9 influenza that emerged in China this year have developed resistance to the only antiviral drugs available to treat the infection, but testing for antiviral resistance can give misleading results, helping hasten the spread of resistant strains.
The authors of a study published in mBio®, the online open-access journal of the American Society for Microbiology, characterized viruses taken from the first person known to be stricken with H7N9 influenza and found that 35% of those viruses are resistant to oseltamivir (commercially known as Tamiflu) and zanamivir (Relenza), front line drugs used for treating H7N9 infections. However, lab testing of the viruses, which detects the activity of a viral enzyme, fails to detect that these strains are resistant, so monitoring for the development of resistance using this technique would prove futile.
"If H7N9 does acquire human-to-human transmissibility, what do we have to treat it with until we have a vaccine? Oseltamivir. We would be in big trouble," says corresponding author Robert Webster of St. Jude Children's Research Hospital in Memphis, Tennessee. Resistant strains of H7N9 can flourish in patients treated with oseltamivir or zanamivir, he says, inadvertently leading to the spread of resistant infections.
In the mBio study, the authors tested antiviral susceptibility of an H7N9 strain isolated from the first confirmed human case of avian H7N9 influenza using a method that tests the activity of the neuraminidase enzyme. The reassuring results were, unfortunately, misleading: the enzyme-based test indicated that the flu strain was susceptible to NA inhibiting antiviral drugs, but it is not.
A closer look at the viral isolate revealed it is actually made up of two distinct types of H7N9 viruses. Roughly 35% of the viruses carry the R292K mutation, making them resistant to NA inhibitors, and 65% are sensitive to these same drugs. The enzyme-based testing gave misleading results, says Webster, because the functioning wild-type enzymes masked the presence of the non-functioning mutant enzymes.
Using NA inhibitors to treat a patient infected with a resistant strain of H7N9 only encourages the virus to proliferate and can lead to enhanced spread of the resistant strain. The authors write that these results prove that it is crucial to use a gene-based surveillance technique that can detect these resistant influenza strains in a mixed infection.
H7N9 first emerged in China in early 2013, in some cases infecting individuals who had been in contact with poultry or with places where poultry are housed. The virus has since been detected in poultry at live markets near where human infections have been reported. After the closure of many live poultry markets in China and with the start of the warm season, which is not conducive to influenza spread, the infection rate appears to have slowed. As of July 12, the number of infections stands at 132 and the number of deaths at 43.
A recent study found that antiviral treatment failed in two patients infected with a strain of H7N9 influenza that carries a mutation called R292K, and that these patients had a poor clinical outcome. The mutation causes a change in the neuraminidase gene and makes the virus resistant to neuraminidase (NA) inhibitors, including Tamiflu and Relenza. NA inhibitors have been the front line therapeutic option for treating H7N9 influenza because the virus is already resistant to M2 ion channel blockers Amantadine (Symmetrel) and its methyl derivative Rimantadine (Flumadine). Considering the severity of H7N9 flu infection and the fact that so few options exist for treatment, it is important to continue to evaluate the sensitivity of clinical isolates to NA inhibitors and to monitor for the emergence of resistant variants.
If the recent history of H5N1 influenza is a guide, says Webster, then H7N9 could rapidly evolve the ability to spread from person to person. If it does, and if the virus reemerges in the fall, the situation with H7N9 could become quite serious. In the event of a widespread outbreak, Tamiflu and Relenza will work alright as treatments, but the development of the R292K mutation puts those options in jeopardy, says Webster.
But the news isn't all bad. Webster also points out that antiviral resistance is something of a burden for influenza viruses, and that fitter wild-type H7N9 strains may eventually win out over resistant strains. In the absence of a drug like Tamiflu, Webster says, it seems unlikely that these resistant viruses would acquire epidemic characteristics.
Regardless of the specific evolutionary steps H7N9 will take, influenza is an ongoing threat - and the lack of suitable drugs is a grave cause for concern.
"The great need at the moment are additional drugs aimed at additional sites in the influenza genome. There are some [drugs] in the pipeline, but they are still under testing at the moment," says Webster. "We'd better get some vaccine seed stocks up and ready. The antiviral option for controlling H7N9 isn't too good."
###
mBio® is an open access online journal published by the American Society for Microbiology to make microbiology research broadly accessible. The focus of the journal is on rapid publication of cutting-edge research spanning the entire spectrum of microbiology and related fields. It can be found online at http://mbio.asm.org.
The American Society for Microbiology is the largest single life science society, composed of over 39,000 scientists and health professionals. ASM's mission is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide.
H7N9 influenza strain resistant to antivirals, but tests fail to identify resistance
2013-07-16
ELSE PRESS RELEASES FROM THIS DATE:
RNA-interference pesticides will need special safety testing
2013-07-16
Standard toxicity testing is inadequate to assess the safety of a new technology with potential for creating pesticides and genetically modifying crops, according to a Forum article published in the August issue of BioScience. The authors of the article, Jonathan G. Lundgren and Jian J. Duan of the USDA Agricultural Research Service, argue that pesticides and insect-resistant crops based on RNA interference, now in exploratory development, may have to be tested under elaborate procedures that assess effects on animals' whole life cycles, rather than by methods that look ...
Inner speech speaks volumes about the brain
2013-07-16
Whether you're reading the paper or thinking through your schedule for the day, chances are that you're hearing yourself speak even if you're not saying words out loud. This internal speech — the monologue you "hear" inside your head — is a ubiquitous but largely unexamined phenomenon. A new study looks at a possible brain mechanism that could explain how we hear this inner voice in the absence of actual sound.
In two experiments, researcher Mark Scott of the University of British Columbia found evidence that a brain signal called corollary discharge — a signal that helps ...
New research shows that temperature influences tropical flowering
2013-07-15
Tropical trees and hanging vines burst into flower, showering the ground below with bright blossoms. Temperature, rather than cloud cover, may be key to the timing of tropical flowering events according to research at two sites in the Smithsonian Institution Global Earth Observatory Network published online in Nature Climate Change.
Scientists discovered a significant increase in flower production—about 3 percent more flowers produced on average per year since 1987—on Barro Colorado Island's Forest Dynamics Plot in Panama.
"Barro Colorado Island was chosen for this study ...
Women who suffered severe sexual trauma as kids benefit most from intervention
2013-07-15
A UCLA-led study of HIV-positive women who were sexually abused as children has found that the more severe their past trauma, the greater their improvement in an intervention program designed to ease their psychological suffering.
The study, conducted by researchers at UCLA's Collaborative Center for Culture, Trauma and Mental Health Disparities, suggests that such interventions should be tailored to individuals' experience and that a "one size fits all" approach may not be enough to successfully reduce women's depression, post-traumatic stress and anxiety symptoms. ...
Can supplementing vitamin D reduce infections in patients from neurosurgical ICU?
2013-07-15
Vitamin D influences many other physiological processes, including muscle function, cardiovascular homeostasis, nerve function, and immune response. Furthermore, accumulated evidence suggests that vitamin D also mediates the immune system response to infection. Infections are very common in patients from neurosurgical intensive care unit. A recent study published in the Neural Regeneration Research (Vol. 8, No. 16, 2013) detected serum vitamin D level in 15 patients with clinically suspected infection and 10 patients with confirmed infection, who came from neurosurgical ...
An embolic agent in the rete mirabile induces ischemic stroke in miniature pigs
2013-07-15
Rodents are frequently used as animal models for ischemic stroke studies induced by middle cerebral artery occlusion. However, their anatomic structure is significantly different from humans. Thus, recent studies have focused on developing stroke models in large animals with similar anatomic structure as the human brain. The swine have several properties resembling the human brain, including brain volume and weight, quantity of cortical gyri and the percentage of white matter to gray matter. These properties allow evaluation of conventional cerebral imaging techniques and ...
Rat hippocampal neurons: An executor of neuroinflammation
2013-07-15
Recent findings suggest that Toll-like receptor 4 expressed in the central nervous system, especially in glial cells, plays a vital role in neuroinflammation and neurodegenerative conditions. Traditional theory suggests that neurons are injured by inflammatory factors released from glial cells, and that neurons are the victims of neuroinflammation. However, it has recently been suggested that Toll-like receptor 4 is expressed by cerebral cortical neurons. Yae Hu and team from Medical School of Nantong University found that lipopolysaccharide participates in neuroinflammation ...
Surprise finding reveals how adaptive our immune systems can be
2013-07-15
Studies of patients with immunodeficiencies involving single gene mutations can reveal a great deal about our immune systems, especially when actual symptoms do not accord with clinical expectations.
Australian scientists acknowledge such a gap between expectation and reality in a new study, which examines people with 'Autosomal Dominant Hyper IgE Syndrome'.
Hyper IgE Syndrome arises from a mutation in the STAT3 gene. This makes patients slightly more susceptible than normal to blood cancers known as 'lymphomas', and exposes them to recurrent skin infections and pneumonia. ...
Is the ice in Greenland in growing decline?
2013-07-15
The time period of satellite observations of the ice sheets of Greenland and the Antarctic is still too short to be able to say whether the accelerated loss of ice measured today will persist in the future. This is the result published today in the online edition of "Nature Geosciences" by a research team led by Bert Wouters from the University of Bristol. The GFZ German Research Centre for Geosciences is also involved in the study. The researchers conclude that predictions of the contribution of both ice shields to the sea level up to the year 2100 may be more than 35 ...
JCI early table of contents for July 15, 2013
2013-07-15
An "obesity-risk" allele alters hunger-stimulating hormone production
Individuals carrying the "obesity-risk" allele of the fat mass and obesity associated gene, FTO, are prone to obesity and obesity related eating behaviors such as increased food consumption, preference for high fat foods and lack of satiation after eating. How this particular gene regulates obesity prone behaviors is not fully understood. In this issue of the Journal of Clinical Investigation, Rachel Batterham and colleagues at University College London identify a link between FTO and the hunger-stimulating ...